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Title:  Zymosan Activation of TLRs: Stimulation of Innate Immunity and Nitric Oxide Production 
Abstract:  
 Chronic inflammation can result in pathophysiological changes to numerous organs of the body 
such as heart tissue (atherosclerosis) and damage to bone.  Sources of inflammation can include 
autoimmune disease, cancer, and chronic infections such as those triggered by HIV or Mycobacterium 
tuberculosis.  Most of the damage associated with chronic inflammation can be associated with chemical 
mediators, cytokines, given off by cells of the innate immune system.  One measure of an active innate 
immune system can be assessed by quantifying nitric oxide (NO) production by bone marrow (BM) cells. 
The purpose of these experiments is to determine if zymosan, a known inflammatory molecule 
associated with yeast cell wall, could stimulate cells of the innate immune response to produce 
cytokines capable of inducing NO production by BM cells.  In these experiments mouse spleen cells were 
used as a source of innate immune cells and BM cells as the NO producing cell.  In vitro, SpC and BM 
were cultured with yeast and NO production measured by the Greiss assay.  In vivo mice were injected 
with yeast in the footpad and 48 hours later BM was removed and cultured and tested for NO 
production.   
In vitro and in vivo experiments show that yeast could stimulate cells of the innate immune 
system to produce cytokines that could activate NO production.  The levels NO produced were low but 
significant.  The results show that yeast can activate cells of the innate immune system and potentially 
be a source of chronic inflammation. 
Introduction: 
Recognition of pathogens by cells of the immune system exists in two distinct 
immunological pathways.  The host organism responds to a pathogen through a nonspecific innate 
immune response, followed by a specific adaptive response.  The innate immune response relies on 
pattern recognition molecules that respond to a wide range of stimuli.  The goal of this experiment 
is to observe the role a species of yeast, Sarccharomyces cerevisiae, plays in the activation of the 
innate immune system.  Yeast are small, single cell organisms that play a role in the production of 
foods such as baked goods and beer.  However yeast can also act as pathogens inducing tissue 
damage and disease.  Yeast infections will stimulate cells of the innate immune system via 
pathogen-associated molecular pattern (PAMP)s found on their surface.   Zymosan, found of the 
surface of yeast is the primary PAMP responsible for immune activation. This PAMP stimulates the 
toll like receptors (TLRs) within the innate immune system to trigger a response.  Zymosan acts by 
binding  to TLR-2 and TLR-6.  TLR-2 plays a fundamental role in pathogen recognition and the 
activation of the innate immune response by the mediating the production of cytokines.  It most 
commonly mediates a cytokine response to Gram positive bacteria and yeasts.  TLR-6 functionally 
interacts with TLR-2 to mediate a cellular response to bacterial lipoproteins (Osamu, 2001).  Once 
TLRs are activated, a number of possible cytokines can be released these include IL-8, IL-6, TNFα, 
and IL-12.  Cytokines can travel throughout the body to activate physiological responses.  
 When the innate immune system is triggered, the cytokines that are produced will travel 
via the blood to effect many organ systems.  Cytokines will stimulate the bone marrow to perform a 
number of functions, such as increasing the production of leukocytes that will enter circulation and 
travel to sites of the inflammation.  Initial cytokines will also stimulate additional responses from 
both BM and circulating leukocytes.  One such response is the production of nitric oxide (NO) 
(Bogdan, 2001).   
Nitric oxide is produced by macrophages, mature neutrophils, dendritic cells, osteoclasts 
and immature neutrophils.  NO production is the result of the nitric oxide synthase.  There are three 
forms of the NO synthase neuronal, endothelial and immune (Bogdan, 2001).  Immune, also called 
inducible NO synthase (iNOS) is the form of the enzyme that is important for immunological 
responses.  NO produced by cells of the immune system is important for destruction of pathogens, 
immune regulation and bone formation.  While low levels of NO appear to promote bone formation 
high levels induce damage and potential osteoporosis (Hamilton, 2013).  Osteoporosis is a common 
symptom of patients with chronic inflammation.   NO produced by macrophages and pre-
neutrophils are also associated with synovial fluid of patients with rheumatoid arthritis (Farrell, 
1992).  Inflammation caused by the autoimmune disease, recruits cells from the BM that upon 
arrival will be stimulated, amplifying the inflammatory response.  In this environment NO is 
produced that will cause additional damage to the joint.   
As implied transcription and translation of iNOS is induced by triggering cell surface 
receptors that will trigger the downstream events that will lead to enzyme synthesis.   The iNOS 
promoter binds transcription factors involved in the activation of other genes by different 
cytokines.  Transcriptional control of the promoter is fulfilled by a number of cytokines, such as the 
inducer role of IFN-γ in combination with LPS or another secondary signal (Kroncke, 1998).  During 
transcription IFN-γ acts as an inducer, however, once transcription has occurred IFN-γ can act to 
stabilize the mRNA.  The protein NF-kappa b acts to control transcription of iNOS (Xie and Nathan, 
1994). Nitric oxide is produced by the bone marrow of the host organism when the innate immune 
response is triggered.  A measure of this nitric oxide release by the bone marrow will indicate the 
amount of stimulation the innate immune system is undergoing in response to pathogens, such as 
zymosan.  
The purpose of this paper is to determine if zymosan can act to stimulate NO production by 
BM cells in vivo and in vitro. 
Materials and Methods: 
Murine Organ Harvest 
 Syngenic C57Bl/6 female mice (Jackson Labs, Bar Harbor Main), 6 months of age were used 
in all experiments.   We acquired in the experiment to ensure that the results do not deviate due to 
a specific specimen’s immune system.  Animal studies were approved by The University of Akron’s 
Animal Care and Use Committtee.  The mouse was sacrificed, using aseptic technique the spleen, 
tibias, and fibulas were harvested.  The bones were cleaned to remove any remaining connective 
tissue and a scalpel was used to trim the edges and expose the bone marrow.  Once removed the 
organs were placed in separate sterile petri dishes containing basal essential media (BEM) (Sigma, 
St Louis Mo.).  
 
 
Singe Cell Suspension-Spleen 
 Under sterile conditions a single cell suspension of spleen cells was created.  Excess fat 
present on the spleen was removed using a scalpel.  Then the plunger of a 5cc syringe was used 
to press the spleen through a 100 mesh stainless steel wire mesh.  This released the spleen cells 
into the BEM solution.  Once the cells were suspended in the BEM, they were transferred to a 15ml 
sterile centrifuge tube using a pasture pipet.  The petri dish was then rinsed with fresh BEM.  The 
test tube was then centrifuged for 7 minutes, 80 C, at 450 X g to form a pellet. 
 
Single Cell Suspension-Bone Marrow 
 A single cell suspension of bone marrow was created by flushing the removed tibias and 
fibulas with BEM using a 22-gauge needle and syringe.  The syringe was filled with BEM, and the 
needle was pressed into the cavity containing the bone marrow.  The cells were collected and 
placed in to a centrifuge tube and treated as above. 
 
Washing Cells and Red Blood Cell Lysis 
 After centrifugation the media was poured off and   approximately 3 to 5 mL of TRIS-
ammonia chloride buffer was added to the test tube, and the pellets were re-suspended.  Tubes 
were incubated for five minutes to lyse red blood cells.  After five minutes, the test tubes were filled 
to approximately 12 mL with fresh BEM and centrifuged.  The supernatants were then poured off 
and the pellet was re-suspended in 4 mL of BEM.  The test tube was filled with BEM and 
centrifuged.  This acted as a wash cycle to ensure all of the TRIS buffer was removed.  This wash 
cycle was repeated for the spleen cells.  The pellet was then suspended in fresh tissue culture 
media. 
 After the second wash BM cells were placed in 7ml of tissue culture media (TCM) and placed 
into a 25cm2 tissue culture flask (Costar) and incubated for 1hr in a humidified 6.0% CO2 incubator at 
37°C.  This removes mature macrophages from the cell suspension, which are capable of both 
inducing and inhibiting nitric oxide production.  After the incubation, the bone marrow cells were 
replaced in a test tube, filled with fresh TCM, and centrifuged. 
 
Solution Protocols 
Fresh TCM:  91.0 mL of manufacturer standard RPMI, 1.0 mL of 10 mM HEPES, 1.0 mL of 5x10 M 
2-Mercaptoethanol, 1.0 mL of 200 mM glutamine, 1.0 mL of penicillin streptomycin (100 g 
streptomycin 100 units penicillin/mL), and 5.0 mL of 5% fetal calf serum.  These chemicals were 
combined within the hood to avoid contamination, then filter sterilized through a 0.2um filter 
(Costar, Corning NY). 
 
Yeast Solutions:  The stock yeast solution was created using Red Star baking yeast.  Exactly 22 mg of 
yeast was dissolved in 22 mL of PBS to form a 1 mg/mL solution. The solution was sterilized by 
autoclaving and then stored at 4℃.  This stock solution was then used in a serial dilution to form the 
following solutions: 10 µg/mL, 1.0 µg/mL, 0.1 µg/mL, and 0.01 µg/mL.  These concentrations of 
yeast (10, 1.0, 0.1, and 0.01 μg/mL) were chosen based upon a range determined by previous 
literature. 
 
Cell Counts 
 To determine cell counts the cells were diluted in the viability stain trypan blue.  The 
solution was loaded into a hemocytometer and counted.   Once a count was achieved, the number 
of cells per milliliter was calculated using the following calculation:   
Number of cells counted x dilution value x 10^4,hemocytometer volume = # cells per 
milliliter 
Once the cells per milliliter was calculated, the cells were diluted to the desired concentration in 
TCM.    
 
In vivo Mouse Experiment 
 The in vivo experiment was conducted using two mice.  Mice were injected with zymosan 
20ul of 1mg/ml into the footpad of both hind limbs.  After 48 hours, the mice were sacrificed and 
their tibias and fibulas were removed.  
 
Spleen Cell Supernatant Cultures 
 The wells of a sterile 96 well plate were added mixtures of TCM, 2.5X10^5 spleen cells/well 
and three different concentrations of yeast.  A negative control, containing only spleen cells and 
media, and a positive control, containing spleen cells in combination with alpha galactose ceramide 
(α Gal-Cer) (DiagnoCine, Hackensack, NJ) (10 ng/mL) and media, were used as positive and negative 
controls respectively. Three different concentrations of yeast were combined with spleen cells: 10 
μg/mL, 1 μg/mL, and 0.1 μg/mL.  The α Gal-Cer stimulates NK T-cells, which makes it a prime 
candidate for a positive control that stimulates action in the innate immune cells (Kitamura, 1999). 
 All wells contained a final volume of 250ul.  The plate was incubated for 48 hours for cells of the 
innate immune system to respond with the production of cytokines. The supernatants were 
harvested and centrifuged at 2000 RPM for 12 minutes to remove spleen cells.  After centrifugation 
the supernatants (sup) were separated from the cell pellet and placed in fresh test tubes.  These 
supernatants were kept on ice until they were added to cultures of bone marrow cells. 
 
Nitric Oxide Production 
Cell cultures were carried out in 96 well flat bottom plates in a final volume of 250 µL. Each 
set of experimental cultures were run in triplicate.   The different biological reagents used for 
plating included LPS (Sigma) (3.3 µg/mL), IFN-γ (Prospect, Revolt Israel) (25 units/mL or 5 units/mL), 
yeast of differing concentrations, cell supernatants, and cell suspensions.  The well was adjusted to 
a final volume of 250ul using TCM.  To determine the amount of NO produced in the culture 50ul of 
culture supernatant was removed at the time indicated in the figures and mixed with Greiss 
reagent.  Cultures containing BM cells and stimulating agents were assayed at 48 and 72 hours, 
while cultures containing BM, Spc and yeast were assayed at 96 hours.   
 
NO assay 
NO is a gas that is rapidly reduced to nitrate in culture.   A standard curve was generated by 
dissolving nitrate into 100, 50, 25, 12.5 and 6.25 uM concentrations.  To 50ul of nitrate was added 
50 ul of Greiss reagent and incubated for 5 minutes and then the absorbance determined at 450nm 
(Sun, 2003).  The standard curve was used via a regression analysis to determine NO concentration 
per culture supernatant of nitrate. 
 
Nitric Oxide Readings   
 After the plates were incubated for periods ranging between 48 and 96 hours, they were 
sampled for nitric oxide production.  A total of 50 μL of each sample was placed into a clean well 
plate inside a Laminar flow hood.  Exactly 50 µL of Greiss reagent was then added to the samples. 
 After a 5 minute period, the well plate was placed within the spectrophotometer and the values for 
nitric oxide were read.  These values were compared to the standard curve to determine the 
amount of nitric oxide produced by each sample using a regression analysis. 
 Statistics 
 To determine if a significant difference in NO production occurred a paired T test was 
performed.   
 
Results: 
 The goal of the first experiment was to determine the effects of yeast on NO production for BM 
and SPC alone or in the presence of stimulating agents, such as IFN−γ and LPS, singularly or in 
combination.  Figure 1 shows the results of the preliminary test of spleen cells in combination with bone 
marrow cells.  As shown, the addition of yeast to the cultures increased NO production in a dose 
dependent manner.  This experiment also included wells with 0.01 µg/mL yeast solution.  This portion of 
experimental wells indicated an abnormally high concentration of NO production compared to both the 
Y=0.1 µg/mL and the control wells containing no yeast, suggesting some form of error.   
 
Figure 1: Nitric oxide production by cultures of BM and SPC incubated with S. cerevisiae with or without LPS or 
IFN-γ.  Cultures containing 2.5x10⁵ cells/well spleen cells and 4.0x10⁵ cells/well BM were incubated with LPS (3.3 
µg/mL) and IFN-γ (25 units/mL) with the indicated concentrations of yeast.  Cultures were incubated for 72 hours 
and 96 hours, then the supernatants were tested for nitric oxide content. 
Figure 2: Nitric oxide with S. cerevisiae  Cultures containing 3.5 x 10⁵ BM cells were incubated with LPS (3.3 µg/mL) and IFN-γ 
with the indicated concentrations of yeast.  Cultures were incubated for 48 (top graph) and 72 hours, then the supernatants 
were tested for nitric oxide content. 
  As seen the largest increase in NO production came from cultures containing yeast and IFN−γ, 
suggesting that the yeast acted to stimulate cells of the innate immune system to produce a cytokine 
that acts synergistically with IFN−γ.   The results in figure 1 do not indicate if the cells of the innate 
immune system responding to yeast is found in the SpC or BM cell population.  Results in other systems 
suggest that the spleen is contributing the cells of the innate immune system that are stimulated by the 
yeast.  The next experiment was performed to see if yeast could enhance NO production by BM cells in 
cultures without SpC.  
The second experiment shows the effect that yeast has on bone marrow cells alone.  The  
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Figure 3: Injecting yeast into the foot pads of mice enhanced NO production by BM cells.  Mice were injected in the hind foot 
pad with a yeast suspension.  48 hours later the BM cells were removed and cultured with the indicated
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received sterile PBS. After 48 hours, the mice were sacrificed and the bone marrow harvested and 
cultured with stimulating agents, seen in Figure 3.  
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 The final experiment was to see SpC could be stimulated by yeast, in vitro, to produce cytokines 
that could stimulate NO production by BM cells
suspensions for 48 hours.  After incubation, the supernatants were harvested and placed in cultures 
containing BM cells and IFN−γ.  Culture
positive control.  BM cells were cultured with superna
production.  Only one significant difference was present
based on the significant difference (p=0.0342) between the positive and negative controls containin
150 μL of supernatant and IFN−γ.  These controls were then compared to the supernatants with yeast at 
10 μg/mL, 1 μg/mL, and 0.1 μg/mL.  Though none of the results indicate significant differences
 
Discussion: 
Nitric oxide is a gas, produced by cells of the 
has anti-microbial effects via its oxidizing activity on bacteria and viruses, and it has a role in molecular 
signaling and communication.    NO associated with endothelia cells 
produced and important in vascular tonicity and neuronal development 
Cells of the immune system only produce NO after stimulation by cytokin
containing specific, PAMPs.  Immune NO, referred to as inducible NO, is produced 
inducible nitric oxide synthase (iNOS).  Transcription of the iNOS gene requires induction of two 
separate transcription factors: NF-kB and an interferon stimulated response element (I
2003).   The NF-kB factor is released from the cytoplasm of the cell after stimulation by a various 
Figure 4: Nitric oxide production by cultures containing BM in combination with spleen cell supernatants and IFN (25 units/mL).  
The positive and negative control indicate a significant difference, p=0.0342, when supernatant was combined w
Differences, though insignificant, were also detected when 150 μL of supernatant containing 0.1 μg/mL of yeast was combined 
with IFN-25.  The supernatants of the SPC solution were combined with 4.0x10
The supernatants were then tested for nitric oxide content.
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cytokines such as TNF-alpha and IL-1beta.  In addition, LPS an integral compound in Gram negative 
bacteria is a very potent activator of NF-kB.  Cells of the innate immune system are an excellent source 
of the cytokines that stimulate release of NF-kB. Stimulation of cells with interferon induces the 
transcription and translation of the ISRE factor.  ISRE then binds to the promoter of the iNOS gene.  
Once the NF-kB factor binds with ISRE, the iNOS gene is transcribed.  The purpose of these experiments 
is to determine if yeast particles can activate cells of the innate immune system to produce the 
cytokines that can activate the NF-kB pathway and NO synthesis.   
The cell wall of yeast molecules contain the PAMP zymosan.  Zymosan is known to bind to TLR-2 
and TLR-6, receptors on the surface of the innate immune system and induce cytokine production (Paul, 
2008).  In the first experiment I wanted to determine if yeast could stimulate cells of the innate immune 
systems to produce cytokines that stimulate NO production.  Yeast was added to cultures containing 
SpC, a source of innate immune cells, and BM.  The BM cells contain the NO producing cells that interact 
with the cytokines produced by the SpC cells.  Cultures were created with or without additional 
stimulating agents. This experiment showed that yeast could stimulate the production of cytokines that 
acted synergistically with IFN-γ to stimulate NO production.  In the next experiments I wanted to 
determine if the SpC were necessary for NO production, or if cells of the low concentration of innate 
immune cells found in BM could be a source of cytokines.  Results showed that a weak but significant 
amount of NO was produced from cultures containing only BM and yeast, but this significant result was 
not reproducible.  One interpretation could be that while cells of the innate immune system are found in 
the BM their numbers are low and resulting in very low cytokine production.   
To further examine the role of the innate immune cells, yeast was injected into the footpads of 
mice.  After 48 hours, BM cells were removed and tested for NO production.  Previous experiments 
using the adjuvant complete Freunds and the NK-T stimulating agent α-galactose cerimide resulted in an 
enhanced ability of BM to produce NO.  It has been reported that injection of stimulating agents in the 
footpad can result in cytokine production within 17 hours that can act in an endocrine fashion on the 
BM (Vitoriano-Souza, 2012).  Results from this experiment support the role of the innate immune 
system in activating NO producing cells.   
Finally I wanted to determine if cell supernatants from SpC cultured with yeast could stimulate 
NO production when mixed with BM cells and IFN-γ.  Spc were cultured with yeast (10, 1, or 0.1ug/ml), 
a-Gal Cer (positive control) or just media alone (negative control).  NO production in this experiment 
was low, making the results difficult to interpret.  BM cells incubated with media from SpC incubated 
with α-Gal Cer did produce a significant amount of NO when incubated with 150ul of conditioned media 
compared to the control (figure 4). The significant difference did not exist when BM cells were incubated 
with only 50 μL of supernatant, indicating that the cytokine(s) produced dilute out quickly.  While media 
from SpC incubated with 0.1 ug/ml of yeast produce levels of NO above the control, they were not 
significant.  The large standard error and low concentrations of NO produced, are the main reasons for 
the insignificant result.  This indicates that with slight protocol modifications, a supernatant could be 
generated that would stimulate NO production in BM cells. 
These results support the hypothesis that yeast cells can stimulate cells of the innate immune 
system to secrete cytokines which enhance NO production.  In vivo experiments demonstrate that 
within 48 hours of injecting the yeast, cytokines are produced that act on the NO producing cells of the 
BM.  This stimulation primes the BM cells for subsequent NO production upon stimulation.  In vitro 
experiments show that yeast has little effect on the BM, also suggesting that BM contains only a few 
cells responsive to the yeast particles.  Significant amounts of NO were also produced when cultures 
contained all three ingredients: SpC, BM, and yeast.  This provided the cultures with a source of innate 
immune cells, a source of NO producing cells, and the zymosan particles.  
Yeast cell wall contains zymosan, a known pathogen associated molecular pattern (PAMP) 
molecule.  Zymosan, has been shown to combine with TLR2 to stimulate production of cytokines such as 
IL-6 and IL-8.  Both IL-8 and IL-6 activate the MAP kinase pathway and the NF-kB signaling pathway 
(Nomi, 2010).  Other sources suggest that the cytokine IL-8 can also effect the ERK pathway, as well as 
the NF-kB pathway (Carta, 2013).  Zymosan has been found to stimulate IL-8 production early in the 
innate immune response, at the point where neutrophils interact with mitogens (Au, 1994).  IL-8 and IL-
6 seem to be the top cytokine candidates in stimulating NO production.  IL-6 is a pro-inflammatory 
cytokine secreted by both T-cells and macrophages, and IL-8 is an inflammatory cytokine produced by 
macrophages.  Either may act as the secondary signal to stimulate the NF-kB receptor, then combine 
with IFN−γ to activate the iNOS gene.  It should be possible to identify the cytokines that zymosan 
produces by generating supernatants from SpC incubated with yeast.  The initial experiment presented 
here did not give a significant result, however further experiments should be performed to attempt to 
optimize the experimental conditions.  
Limitations: 
 This project was completed using common baking yeast, Sarccharomyces cerevisiae, which has 
one PAMP associated with it.  There are other species of yeast containing different PAMPs that will 
stimulate TLRs other than TLR-2 and TLR-6.  Pathogenic yeasts, such as the Cryptococcus genus and 
Candidia albicans, may have a different stimulating effect on the innate immune system.  For example, 
Candidia albicans is an opportunistic pathogen that can invade the mucous membranes and cause 
significant damage when the immune system is compromised.  This species of yeast has PAMPs such as 
mannan and O-linked mannosyl residues that activate TLR-4.   TLR-4 will activate a different cytokine 
response that may produce a different amount of nitric oxide in the bone marrow, which indicates a 
difference in innate immunity stimulation.  
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